Article Text
Statistics from Altmetric.com
Demyelinating disorders of the central nervous system (CNS) may be divided into primary (cause unknown, eg, multiple sclerosis (MS)) and secondary (eg, infective, hypoxic–ischaemic, metabolic, toxic) processes. The underlying cause damages the myelin sheath and/or oligodendrocyte. MRI is the imaging modality of choice because of its high spatial and contrast resolution, but imaging features are often non-specific.
The most common causes of multifocal white matter lesions are perivascular spaces (not discussed here), ischaemia (small vessel disease) and MS. Small vessel disease is much more common than MS, hence, their distinguishing features are discussed first.
Small vessel disease
Vascular white matter lesions are age-related, asymptomatic foci of ischaemic demyelination (unidentified bright objects or ‘UBOs’), myelin pallor or gliosis. They are uncommon in those below age 40 years (figure 1), thereafter, increasing in frequency with age. These white matter changes occur in 5–10% of those aged 20–40 years. Most patients are neurologically normal. At all ages, the incidence and lesion load increase with cardiovascular risk factors (figure 2). The white matter lesions are small and have high T2 signal but differ from MS plaques because of their irregular shape, poor definition and peripheral location and are most common in the frontal and parietal lobes. Posterior fossa lesions are uncommon, and callosal lesions are rare because of a dual blood supply.
Footnotes
-
Competing interests None.
-
Provenance and peer review Commissioned; internally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Imaging in multiple sclerosis and related disorders
- Imaging evaluation of demyelinating processes of the central nervous system
- Imaging in multiple sclerosis
- Immune-mediated conditions affecting the brain, eye and ear (BEE syndromes)
- Back on the scent: the olfactory system in CNS demyelinating diseases
- A practical review of the neuropathology and neuroimaging of multiple sclerosis
- Neurodegeneration in multiple sclerosis and neuromyelitis optica
- Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort
- CNS inflammatory demyelinating disorders: MS, NMOSD and MOG antibody associated disease
- Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS